Yu Waye Chu
Chief Tech/Sci/R&D Officer at CYTOMX THERAPEUTICS, INC.
Net worth: 1 M $ as of 30/03/2024
Profile
Yu Waye Chu holds the position of Senior Vice President-Clinical Development at Fate Therapeutics, Inc. He received an undergraduate degree from Princeton University and a doctorate from the University of Rochester School of Medicine & Dentistry.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
FATE THERAPEUTICS, INC.
0.14% | 17/04/2023 | 140,676 ( 0.14% ) | 1 M $ | 30/03/2024 |
| 17/01/2024 | 26,250 ( 0.04% ) | 57 225 $ | 30/03/2024 |
Yu Waye Chu active positions
| Companies | Position | Start |
|---|---|---|
| CYTOMX THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 16/07/2023 |
Former positions of Yu Waye Chu
| Companies | Position | End |
|---|---|---|
| FATE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 13/07/2023 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 31/03/2019 |
Training of Yu Waye Chu
| Princeton University | Undergraduate Degree |
| University of Rochester School of Medicine & Dentistry | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| FATE THERAPEUTICS, INC. | Health Technology |
| CYTOMX THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Yu Waye Chu
